Levin Capital Strategies L.P. grew its position in Alpha Tau Medical Ltd. (NASDAQ:DRTS – Free Report) by 288.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 330,123 shares of the company’s stock after acquiring an additional 245,123 shares during the […]
Telemus Capital LLC acquired a new stake in Alpha Tau Medical Ltd. (NASDAQ:DRTS – Free Report) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 29,716 shares of the company’s stock, valued at approximately $89,000. Other hedge funds and other institutional investors have also recently bought and sold […]
Hoylecohen LLC bought a new position in shares of Alpha Tau Medical Ltd. (NASDAQ:DRTS – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 269,088 shares of the company’s stock, valued at approximately $1,020,000. Hoylecohen LLC owned approximately 0.39% of Alpha Tau Medical as of […]
Analysts at Citigroup began coverage on shares of Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) in a report released on Friday, Briefing.com reports. The brokerage set a “buy” rating and a $8.00 price target on the stock. Citigroup’s price objective indicates a potential upside of 184.70% from the stock’s current price. DRTS has been […]
Alpha Tau Medical Ltd. (NASDAQ:DRTS – Get Free Report) was the recipient of a large drop in short interest in November. As of November 15th, there was short interest totalling 65,100 shares, a drop of 8.2% from the October 31st total of 70,900 shares. Based on an average trading volume of 26,500 shares, the days-to-cover […]